CEO, FIND Diagnostics, Switzerland
Philippe Jacon became CEO of the Foundation for Innovative New Diagnostics (FIND)
in October 2011.
As such, he leads the strategy of this not-for-profit, Geneva-based
International Organization and ensures it fulfills its mission to "Drive the development
and early implementation of innovative diagnostic tests that have a high impact on
patient care and disease control in low-resource settings".
Philippe Jacon joined FIND from EDMA (European Diagnostic Manufacturers
Association) where he acted as the Director General ad interim since March of 2011.
Prior to EDMA, he spent most of his career with BD (Becton Dickinson and Co) in
various positions and locations.
Most notably, he was Worldwide President of BD Diagnostics-Diagnostic Systems and
Worldwide President of BD Diagnostics - Microbiology Systems both positions based in
Baltimore, MD; VP/GM Europe BD Medical - Diabetes Care.
Prior to these roles, Mr.
Jacon held positions of increasing responsibility in BD Medical-Pharmaceutical Systems
in Europe and subsequently in the US where he was the VP/GM for the business.
Jacon started his career at BD as a Sales Representative in France for BD Biosciences.
During his time in Baltimore, Mr. Jacon played an active role in the community.
served on the board of the University of Maryland BioPark and the Greater Baltimore
He was also appointed by Governor Martin O'Malley to the Maryland Life
Sciences Advisory Board.
Philippe Jacon has a Microbiologist Engineer degree from the Université de Bretagne
Occidentale in France. He is a French citizen, married and has 3 children.